QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) All Versions of this Article: jpet.103.064907v1 310/1/407    most recent Submit a response Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Jarvis, M. F. Articles by Faltynek, C. Search for Related Content PubMed PubMed Citation Articles by Jarvis, M. F. Articles by Faltynek, C.

NEUROPHARMACOLOGY

[³H]A-317491, a Novel High-Affinity Non-Nucleotide Antagonist That Specifically Labels Human P2X_2/3 and P2X₃ Receptors

Neuroscience Research, Global Pharmaceutical Research and Development, Abbott Laboratories, Abbott Park, Illinois

A-317491 is a potent and selective antagonist of P2X₃ and P2X_2/3 receptors. In the present studies, the ability of [³H]A-317491 to label recombinant human P2X_2/3 and P2X₃ receptors was characterized. Using membranes prepared from 1321N1 cells expressing P2X_2/3 receptors, [³H]A-317491 specifically labeled high-affinity (K_d = 0.9 nM) recognition sites. High-affinity [³H]A-317491 binding was not detected in membrane preparations from native 1321N1 cells or cells expressing homomeric P2X₁, P2X₂, or P2X₃ receptors. Specific [³H]A-317491 P2X₃ receptors could only be reliably detected following treatment of intact P2X₃ receptor-expressing cells with apyrase (1 U/ml) both before and during membrane preparation. Under these conditions, [³H]A-317491 also labeled high-affinity (K_d = 9 nM) binding sites. Lower affinity binding components (K_d values of 87–790 nM) were detected in both assays using higher ligand concentrations that likely represent nonfunctional recognition sites. [³H]A-317491 binding to both P2X_2/3 and P2X₃ receptors was reversible, and ligand kinetic studies provided similar estimates of the high-affinity binding constants. Potent P2X₃ receptor agonists 2-methylthio-ATP, 2,3-O-(4-benzoylbenzoyl)-ATP, and ,-methylene adenosine triphosphate also potently inhibited specific [³H]A-317491 binding to both P2X_2/3 and P2X₃ receptors. The pharmacological profile for P2X receptor antagonists to inhibit [³H]A-317491 binding to P2X_2/3 and P2X₃ receptors was highly correlated (r = 0.98, P < 0.05), and a similar rank order of potency was observed for blockade of P2X_2/3 receptor-mediated calcium influx. These data demonstrate that [³H]A-317491 is the first useful radioligand for the specific labeling of P2X₃-containing channels.

Address correspondence to: Dr. Michael F. Jarvis, R4PM AP9A/2, 100 Abbott Park Rd., Abbott Park, IL 60064-6123. E-mail: michael.jarvis{at}abbott.com

This article has been cited by other articles:

				P. Honore, D. Donnelly-Roberts, M. T. Namovic, G. Hsieh, C. Z. Zhu, J. P. Mikusa, G. Hernandez, C. Zhong, D. M. Gauvin, P. Chandran, et al. A-740003 [N-(1-{[(Cyanoimino)(5-quinolinylamino) methyl]amino}-2,2-dimethylpropyl)-2-(3,4-dimethoxyphenyl)acetamide], a Novel and Selective P2X7 Receptor Antagonist, Dose-Dependently Reduces Neuropathic Pain in the Rat J. Pharmacol. Exp. Ther., December 1, 2006; 319(3): 1376 - 1385. [Abstract] [Full Text] [PDF]

				W. J. Wilkinson, L.-H. Jiang, A. Surprenant, and R. A. North Role of Ectodomain Lysines in the Subunits of the Heteromeric P2X2/3 Receptor Mol. Pharmacol., October 1, 2006; 70(4): 1159 - 1163. [Abstract] [Full Text] [PDF]

				G. Burnstock Pathophysiology and therapeutic potential of purinergic signaling. Pharmacol. Rev., March 1, 2006; 58(1): 58 - 86. [Abstract] [Full Text] [PDF]

				K. K. Ford, M. Matchett, J. E. Krause, and W. Yu The P2X3 Antagonist P1, P5-Di[inosine-5'] Pentaphosphate Binds to the Desensitized State of the Receptor in Rat Dorsal Root Ganglion Neurons J. Pharmacol. Exp. Ther., October 1, 2005; 315(1): 405 - 413. [Abstract] [Full Text] [PDF]